5 TzogiouCWieserSEichlerKCarlanderMDjalaliSRosemannTet al
Full tracking is essential for any extended protocol, with frequency and scope of tracking adjusted based on protocol duration and personal risk factors
Cardiac, metabolic, and liver labs published preclinical work tracked
Ozempic (injectable, weekly, 0.25mg, 0.5mg, 1.0mg, 2.0mg) and Rybelsus (oral, daily, 7mg, 14mg) are FDA-approved for type 2 diabetes, while Wegovy (injectable, weekly, 0.25mg, 0.5mg, 1.0mg, 1.7mg, 2.4mg) is approved for obesity
ReadyRx GLP-1 works through a structured telehealth intake and prescription process
For weekly GLP-1 medications such as semaglutide (Ozempic, Wegovy) and dulaglutide (Trulicity), timing is less critical due to their extended half-lives and sustained therapeutic effects